Literature DB >> 18832876

National estimation of rates of HIV serology testing in US emergency departments 1993-2005: baseline prior to the 2006 Centers for Disease Control and Prevention recommendations.

Yu-Hsiang Hsieh1, Richard E Rothman, David E Newman-Toker, Gabor D Kelen.   

Abstract

OBJECTIVE: The 2006 Centers for Disease Control and Prevention recommendations place increased emphasis on emergency departments (EDs) as one of the most important medical care settings for implementing routine HIV testing. No longitudinal estimates exist regarding national rates of HIV testing in EDs. We analyzed a nationally representative ED database to assess HIV testing rates and characterize patients who received HIV testing, prior to the release of the 2006 guidelines.
DESIGN: A cross-sectional analysis of US ED visits (1993-2005) using the National Hospital Ambulatory Medical Care Survey was performed.
METHODS: Patients aged 13-64 years were included for analysis. Diagnoses were grouped with Healthcare Cost and Utilization Project Clinical Classifications Software. Analyses were performed using procedures for multiple-stage survey data.
RESULTS: HIV testing was performed in an estimated 2.8 million ED visits (95% confidence interval, 2.4-3.2) or a rate of 3.2 per 1000 ED visits (95% confidence interval, 2.8-3.7). Patients aged 20-39 years, African-American, and Hispanic had the highest testing rates. Among those tested, leading reasons for visit were abdominal pain (9%), puncture wound/needlestick (8%), rape victim (6%), and fever (5%). The leading medication class prescribed was antimicrobials (32%). The leading ED diagnosis was injury/poisoning (30%) followed by infectious diseases (18%). Of note, 6% of those tested were diagnosed with HIV infection during their ED visits.
CONCLUSION: Prior to the release of the 2006 Centers for Disease Control and Prevention guidelines for routine HIV testing in all healthcare settings, baseline national HIV testing rates in EDs were extremely low and appeared to be driven by clinical presentation.

Entities:  

Mesh:

Year:  2008        PMID: 18832876     DOI: 10.1097/QAD.0b013e328310e066

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  7 in total

1.  HIV screening practices in U.S. hospitals, 2009-2010.

Authors:  Andrew C Voetsch; James D Heffelfinger; Juliet Yonek; Pragna Patel; Steven F Ethridge; Gretchen W Torres; Margaret A Lampe; Bernard M Branson
Journal:  Public Health Rep       Date:  2012 Sep-Oct       Impact factor: 2.792

2.  Acute HIV infection and implications of fourth-generation HIV screening in emergency departments.

Authors:  Jason S Haukoos; Michael S Lyons; Douglas A E White; Yu-Hsiang Hsieh; Richard E Rothman
Journal:  Ann Emerg Med       Date:  2014-08-13       Impact factor: 5.721

3.  Will patients "opt in" to perform their own rapid HIV test in the emergency department?

Authors:  Charlotte A Gaydos; Yu-Hsiang Hsieh; Leah Harvey; Avanti Burah; Helen Won; Mary Jett-Goheen; Mathilda Barnes; Patricia Agreda; Nick Arora; Richard E Rothman
Journal:  Ann Emerg Med       Date:  2011-07       Impact factor: 5.721

4.  Antiviral prescriptions to U.S. ambulatory care visits with a diagnosis of influenza before and after high level of adamantane resistance 2005-06 season.

Authors:  Yu-Hsiang Hsieh; Kuan-Fu Chen; Charlotte A Gaydos; Richard E Rothman; Gabor D Kelen
Journal:  PLoS One       Date:  2010-01-28       Impact factor: 3.240

5.  Opportunities for HIV combination prevention to reduce racial and ethnic health disparities.

Authors:  Cynthia I Grossman; David W Purcell; Mary Jane Rotheram-Borus; Rosemary Veniegas
Journal:  Am Psychol       Date:  2013 May-Jun

6.  Timing Matters: HIV Testing Rates in the Emergency Department.

Authors:  Rebecca Schnall; Nan Liu
Journal:  Nurs Res Pract       Date:  2014-09-09

7.  Towards ending the human immunodeficiency virus epidemic in the US: State of human immunodeficiency virus screening during physician and emergency department visits, 2009 to 2014.

Authors:  Bankole Olatosi; Khairul Alam Siddiqi; Donaldson Fadael Conserve
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.